Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity: Results of the European PanCareLIFE cohort study

Organic Cation Transporter 2 Mediates Cisplatin-Induced Oto- and Nephrotoxicity and Is a Target for Protective Interventions

Giuliano Ciarimboli, Dirk Deuster, Arne Knief et al. · American Journal Of Pathology · 2010 · 441 citations · Full text

Medicine, Oncology, Pharmacology +15

THE SOCIETAL COSTS OF SEVERE TO PROFOUND HEARING LOSS IN THE UNITED STATES

Penny Mohr, Jacob J. Feldman, Jennifer L. Dunbar et al. · International Journal of Technology Assessment in Health Care · 2000 · 394 citations

Health Professions, Audiology, Special Education +13

Cisplatin and Oxaliplatin, but Not Carboplatin and Nedaplatin, Are Substrates for Human Organic Cation Transporters (SLC22A1–3 and Multidrug and Toxin Extrusion Family)

Atsushi Yonezawa, Satohiro Masuda, Sachiko Yokoo et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 341 citations

Medicine, Cell Biology, Pharmacology +16

Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy

Colin J.D. Ross, Hagit Katzov-Eckert, Marie‐Pierre Dubé et al. · Nature Genetics · 2009 · 328 citations · Full text

Life Sciences, Genetics, Oncology +15

Cisplatin-Induced Long-Term Hearing Impairment Is Associated With Specific Glutathione <i>S</i>-Transferase Genotypes in Testicular Cancer Survivors

Jan Oldenburg, Sigrid Marie Kraggerud, Milada Cvancarova et al. · Journal of Clinical Oncology · 2007 · 195 citations · Full text

Medicine, Genetics, Oncology +17